Credorax appoints Achiya Fried as chief commercial officer

Source: Credorax

Credorax, leading smart payments provider and merchant acquiring bank, has today announced the appointment of Achiya Fried as Chief Commercial Officer.

With almost 25 years’ experience in acquiring, ecommerce and sales and marketing across the cards and payments sector, Fried will be leading on Credorax’s market growth strategy, while heading up the business development and commercial teams.

Prior to joining Credorax, Fried held positions at Israel Credit Cards and Ha’aretz as Executive Vice President of Payment Services and Vice President of Marketing respectively. Achiya was also CEO of Diners Club Israel, fully responsible for all of Diners Club activities in Israel and member of Diners Global Marketing Advisory Board.

Discussing the new role, Achiya Fried commented: “At a time of undoubted opportunity in the payments industry, Credorax is proving itself a key player in the arena. Its committed approach to the very best in customer service, coupled with its desire to bring innovative and disruptive technologies and solutions to market, makes this an exciting time to be joining the company.”

In its role as a smart payments provider, Credorax enables merchants to process payments more easily, offering a range of products and services which have been created to allow for the maximum possible growth for businesses. Credorax also offers approval rate optimisation and analysis, as well as an insights platform which assists in reporting and reconciliation and customized support services for Visa and Mastercard to make sure that no valid payments are denied.

Igal Rotem, CEO of Credorax, added: “Welcoming Achiya to the Credorax family is a strategic step in reaching our ambitious growth goals over the coming twelve months.

“Our solutions are a testament to the talented teams behind them and Achiya’s experience and expertise are impressive to say the very least. With his leadership, we are well positioned to take our company to the next level and I look forward to working closely with him. I’ve no doubt he will quickly become a highly-regarded and invaluable member of Credorax team.”

Comments: (0)